Investors Overview News & Events Company Info Financial Info Stock Data SEC Filings Governance ACCEPT REJECT Company Profile ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. Additionally, ClearPoint is currently used in clinical trials for delivery of biologics, gene, and stem cell therapies to the brain. Our platform has FDA clearance, is CE-marked, and is installed in over 60 active clinical sites in the United States, Canada, and Europe. Latest News VIEW ALL NEWS NOVEMBER 17, 2021 · 4PM EST ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface System VIEW PRESS RELEASE NOVEMBER 9, 2021 · 4PM EST ClearPoint Neuro Reports Third Quarter 2021 Results VIEW PRESS RELEASE NOVEMBER 8, 2021 · 4PM EST ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients VIEW PRESS RELEASE Latest Presentation NOVEMBER 9, 2021 · 12AM EST Investor Presentation VIEW PRESENTATION Latest Event NOVEMBER 16, 2021 · 10AM EST Stifel 2021 Virtual Healthcare Conference VIEW EVENT VIEW ALL EVENTS Latest Financial Results Q3 2021 QUARTER ENDED SEP 30, 2021 Earnings Release PDF HTML Earnings Webcast AUDIO 10-Q Filing PDF HTML XBRL ZIP XLS HTML Latest Annual Filing For Fiscal Year Ending Dec 31, 2020 Report Links Annual Report Document Links VIEW 10-K Email Alerts Sign up today and receive company updates straight to your inbox. SIGN UP TODAY Company Overview ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. Additionally, ClearPoint is currently used in clinical trials for delivery of biologics, gene, and stem cell therapies to the brain. Our platform has FDA clearance, is CE-marked, and is installed in over 60 active clinical sites in the United States, Canada, and Europe. VIEW COMPANY INFO Leadership VIEW MANAGEMENT TEAM VIEW BOARD OF DIRECTORS Investor Contact Information Investor Relations Westwicke (an ICR company) Caroline Corner 150 Spear Street Suite 825 San Francisco, CA 94105 T: 415-202-5678 https://westwicke.com/ Transfer Agent Continental Stock Transfer & Trust Company One State Street Plaza 30th Floor New York, NY 10004 T: 212-509-4000 F: 212-509-5150 https://continentalstock.com Outside Legal Counsel Bass, Berry & Sims PLC 100 Peabody Place Suite 1300 Memphis, TN 38103 T: 901-543-5933 https://www.bassberry.com Email Alerts Contacts RSS News Feed ©2021 ClearPoint Neuro, Inc. All Rights Reserved. Privacy Policy Terms of Use California Compliance Declaration Sitemap Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.